CH510620A - Verfahren zur Herstellung von neuen, blutdrucksenkend wirkenden Hydroxylaminderivaten - Google Patents
Verfahren zur Herstellung von neuen, blutdrucksenkend wirkenden HydroxylaminderivatenInfo
- Publication number
- CH510620A CH510620A CH422069A CH422069A CH510620A CH 510620 A CH510620 A CH 510620A CH 422069 A CH422069 A CH 422069A CH 422069 A CH422069 A CH 422069A CH 510620 A CH510620 A CH 510620A
- Authority
- CH
- Switzerland
- Prior art keywords
- antihypertensive
- new
- production
- hydroxylamine derivatives
- hydroxylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH634171A CH515878A (de) | 1968-03-30 | 1969-03-20 | Verfahren zur Herstellung von neuen, blutdrucksenkend wirkenden Hydroxylaminderivaten |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HURI000343 | 1968-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH510620A true CH510620A (de) | 1971-07-31 |
Family
ID=11000825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH422069A CH510620A (de) | 1968-03-30 | 1969-03-20 | Verfahren zur Herstellung von neuen, blutdrucksenkend wirkenden Hydroxylaminderivaten |
Country Status (10)
Country | Link |
---|---|
US (1) | US3642805A (de) |
JP (1) | JPS4843726B1 (de) |
AT (2) | AT296252B (de) |
CH (1) | CH510620A (de) |
DE (1) | DE1916481C3 (de) |
DK (1) | DK126426B (de) |
FR (1) | FR2007354B1 (de) |
GB (1) | GB1240224A (de) |
NL (1) | NL6904889A (de) |
SE (1) | SE375760B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1322987A (en) * | 1969-12-29 | 1973-07-11 | Richter Gedeon Vegyeszet | On,n-diacylhydroxylamine derivatives and preparation |
US4028401A (en) * | 1976-07-01 | 1977-06-07 | Morton-Norwich Products, Inc. | (Substituted)ureidoacetohydroxamic acids |
US4496541A (en) * | 1983-01-12 | 1985-01-29 | Usv Pharmaceutical Corporation | Compounds for treating hypertension |
JPS6321067U (de) * | 1986-07-26 | 1988-02-12 | ||
US5228899A (en) * | 1989-08-25 | 1993-07-20 | Sumitomo Chemical Company Limited | Hydroxamic acid esters and plant growth regulation therewith |
US5254724A (en) * | 1991-10-30 | 1993-10-19 | University Of Florida Research Foundation, Inc. | Method for synthesis of desferrioxamine B, analogs and homologs thereof |
DE10007308A1 (de) * | 2000-02-17 | 2001-08-23 | Bosch Gmbh Robert | Verfahren und Vorrichtung zur Ermittlung der verbleibenden Betriebsdauer eines Produktes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1167934A (fr) * | 1955-06-28 | 1958-12-03 | Hoffmann La Roche | Procédé pour la préparation de nouveaux dérivés d'alpha-amino-beta-hydroxy-acides |
-
1969
- 1969-03-19 AT AT995670A patent/AT296252B/de not_active IP Right Cessation
- 1969-03-19 AT AT268469A patent/AT293358B/de not_active IP Right Cessation
- 1969-03-20 CH CH422069A patent/CH510620A/de not_active IP Right Cessation
- 1969-03-25 GB GB05666/69A patent/GB1240224A/en not_active Expired
- 1969-03-26 US US810822A patent/US3642805A/en not_active Expired - Lifetime
- 1969-03-28 NL NL6904889A patent/NL6904889A/xx unknown
- 1969-03-28 SE SE6904428A patent/SE375760B/xx unknown
- 1969-03-28 DK DK172369AA patent/DK126426B/da unknown
- 1969-03-31 JP JP44024695A patent/JPS4843726B1/ja active Pending
- 1969-03-31 FR FR6909597A patent/FR2007354B1/fr not_active Expired
- 1969-03-31 DE DE1916481A patent/DE1916481C3/de not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS4843726B1 (de) | 1973-12-20 |
US3642805A (en) | 1972-02-15 |
DE1916481A1 (de) | 1969-10-09 |
GB1240224A (en) | 1971-07-21 |
DE1916481C3 (de) | 1974-06-27 |
FR2007354B1 (de) | 1974-01-11 |
DK126426B (da) | 1973-07-16 |
NL6904889A (de) | 1969-10-02 |
DE1916481B2 (de) | 1973-11-29 |
AT296252B (de) | 1972-02-10 |
FR2007354A1 (de) | 1970-01-09 |
AT293358B (de) | 1971-10-11 |
SE375760B (de) | 1975-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT298451B (de) | Verfahren zur Herstellung von neuen, basisch substituierten Phenolen | |
CH529774A (de) | Verfahren zur Herstellung von neuen Isoxazolderivaten | |
CH548412A (de) | Verfahren zur herstellung von neuen 5-nitrofurylderivaten. | |
CH558342A (de) | Verfahren zur herstellung von neuen phenolderivaten. | |
AT269855B (de) | Verfahren zur Herstellung von neuen 5-Nitrofuran- bzw. 5-Nitrothiopen-Derivaten | |
CH510668A (de) | Verfahren zur Herstellung von neuen 1,6-Dimethyl-10a-ergolinderivaten | |
CH547793A (de) | Verfahren zur herstellung von neuen evomonosid-derivaten. | |
CH510620A (de) | Verfahren zur Herstellung von neuen, blutdrucksenkend wirkenden Hydroxylaminderivaten | |
CH547820A (de) | Verfahren zur herstellung von neuen 5-nitrofurylderivaten. | |
AT309457B (de) | Verfahren zur Herstellung von neuen Nitrofuranderivaten | |
AT322117B (de) | Verfahren zur herstellung von neuen, heterocyclisch substituierten nebularin-derivate | |
CH525893A (de) | Verfahren zur Herstellung von neuen Benzomorphanderivaten | |
CH513147A (de) | Verfahren zur Herstellung von neuen Benzofuranderivaten | |
AT290522B (de) | Verfahren zur Herstellung von neuen Cumarinderivaten | |
AT281816B (de) | Verfahren zur Herstellung von neuen 1,2-Benzixothiazol-Derivate | |
CH518941A (de) | Verfahren zur Herstellung von neuen 3,5-Dioxopyrazolidinderivaten | |
AT281863B (de) | Verfahren zur Herstellung von neuen Hydantoinderivaten | |
AT295144B (de) | Verfahren zur Herstellung von neuen, überwiegend linearen Polybiureten | |
CH546787A (de) | Verfahren zur herstellung von neuen 5-nitrofurylderivaten. | |
AT297949B (de) | Verfahren zur Herstellung von neuen 9β,10α-Steroiden | |
AT303982B (de) | Verfahren zur Herstellung von neuen 7α-Methyl-1α,2α-methylen-androstenolonen | |
AT305267B (de) | Verfahren zur Herstellung von neuen 11-Aminoalkyl-9,10-ätheno-anthracenen | |
AT291280B (de) | Verfahren zur Herstellung von neuen Harnstoffderivaten | |
AT291278B (de) | Verfahren zur Herstellung von neuen Harnstoffderivaten | |
CH554310A (de) | Verfahren zur herstellung von neuen 1-aminoalkylidenbenzcycloalkan-2-spirocycloaliphatischen verbindungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |